Feature | Radiology Business | May 04, 2016

New system will combine data from different sources to generate higher-quality evidence for medical device evaluation and regulatory decision-making

FDA, CDRH, national evaluation system, medical device development

May 4, 2016 — The U.S. Food and Drug Administration (FDA) announced it is building the foundations of a national evaluation system to generate better evidence more efficiently for medical device evaluation and regulatory decision-making. The agency said a national evaluation system would generate evidence across the total product lifecycle of medical devices by strategically and systematically leveraging real-world evidence, and applying advanced analytics to data tailored to the unique data needs and innovation cycles of medical devices.

The collaborative national evaluation system will link and synthesize data from different sources across the medical device landscape, including clinical registries, electronic health records and medical billing claims. The FDA said such a system will help improve the quality of real-world evidence that healthcare providers and patients can use to make better informed treatment decisions and strike the right balance between assuring safety and fostering device innovation and patient access.

The system evolved out of a vision for a medical device post-market surveillance system described in two FDA white papers. The initial report, "Strengthening Our National System for Medical Device Post-market Surveillance," was issued in 2012 and provides an overview of FDA's medical device post-market authorities and the current U.S. medical device post-market surveillance system. The update to the report, issued in 2013, details the concrete steps that will promote more efficient collection of better and more timely data, helping to identify issues more quickly. Subsequently, FDA issued two five-year program announcements (PAR-13-202 and PAR-13-232) requesting proposals from prospective partners to build the scientific infrastructure and methodology necessary to further develop and implement these plans through cooperative agreements.

Under a cooperative agreement with FDA, the Brookings Institution convened a multi-stakeholder planning board as described in the 2013 update. In February 2015, the planning board issued a report titled, "Strengthening Patient Care: Building a National Post-market Medical Device Surveillance System" that sets out the key steps towards development of a national system for development, regulation and effective use of medical devices, while supporting improvements in patient safety and health outcomes.

The system was renamed an "evaluation system" to reflect the broad evidence needs of stakeholders with the August 2015 release of the report "Recommendations for a National Medical Device Evaluation System: Strategically Coordinated Registry Networks to Bridge the Clinical Care and Research." MDEpiNet, a broad-based public-private partnership initially envisioned and launched by FDA in 2010, produced this report and is working to build infrastructure, and develop tools and methods for the national system.

In 2016, the Duke-Margolis Center for Health Policy published "Better Evidence on Medical Devices: A Coordinating Center for a 21st Century National Medical Device Evaluation System." This document further clarifies the expectations, roles and responsibilities of the coordinating center described in the 2015 planning board report. This additional detail provides insight into the expected business practices of an independent, transparent coordinating center that would guide the future development and implementation of the national evaluation system.

The Center for Devices and Radiological Health (CDRH) said that establishing a national evaluation system for medical devices is one of its 2016-2017 strategic priorities.

For more information: www.fda.gov


Related Content

News | Advanced Visualization

July 28, 2025 — Frost & Sullivan has named Siemens Healthineers the 2025 North America Company of the Year in the ...

Time July 28, 2025
arrow
News | X-Ray

July 24, 2025 — GE HealthCare has announced the commercial availability of an advanced floor-mounted digital X-ray ...

Time July 24, 2025
arrow
News | Artificial Intelligence

July 17, 2025 — HOPPR, a secure AI development platform for medical imaging, has announced the commercial release of its ...

Time July 17, 2025
arrow
News | Breast Imaging

July 17, 2025 — RadNet, Inc., a provider of high-quality, cost-effective diagnostic imaging services and digital health ...

Time July 17, 2025
arrow
News | Focused Ultrasound Therapy

July 15, 2025 — Newswise —The UK Focused Ultrasound Foundation and Pancreatic Cancer UK have announced a new partnership ...

Time July 16, 2025
arrow
News | Radiology Imaging

July 15, 2025 — Radiology Partners (RP), a provider of technology-enabled radiology services, has announced the launch ...

Time July 15, 2025
arrow
News | Digital Radiography (DR)

July 10, 2025 — Fujifilm Healthcare Americas Corp. has launched several advanced automated functions for its FDR ...

Time July 10, 2025
arrow
News | Computed Tomography (CT)

July 01, 2025 — NANO-X Imaging Ltd. recently announced a clinical and educational collaboration with Keiser University ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

June 26, 2025 — FUJIFILM VisualSonics Inc., a provider of ultra-high frequency ultrasound and photoacoustic imaging ...

Time June 27, 2025
arrow
News | Imaging Software Development

June 12, 2025 — GE HealthCare has announced the combination of GE HealthCare’s proprietary features and algorithms with ...

Time June 12, 2025
arrow
Subscribe Now